Topical Corticophobia Among Healthcare Professionals in Saudi Arabia: A Cross-Sectional Study
Keywords:
corticophobia, topical steroids, physicians, dermatologists, family medicineAbstract
Introduction: Corticophobia constitutes a complex challenge affecting patients and healthcare professionals alike, resulting in suboptimal management and treatment of dermatological conditions.
Objective: This study aims to investigate corticophobia among physicians in Saudi Arabia and identify associated factors.
Methodology: This is a retrospective, observational, cross-sectional study that included 700 participants. The sample constituted dermatologists, pediatricians, and family medicine practitioners at different levels (consultants, fellows, and residents) in Saudi Arabia. Data were collected via an electronic survey addressing demographic information and corticophobia-related questions. Statistical analysis was performed using Rstudio.
Results: A total of 700 participants were included in the data analysis. Dermatologists were the most comfortable prescribing steroids (32%), followed by family medicine physicians (25%), and pediatricians (18%). Pediatricians were the most hesitant to prescribe steroids. Fellows were the most confident in prescribing steroids. Physicians from the northern and western regions were least likely to be hesitant in prescribing steroids.
Conclusion: In conclusion, this study reveals that in Saudi Arabia, dermatologists were the most comfortable prescribing topical corticosteroids, with pediatricians being the most hesitant. The findings emphasize the importance of education in addressing corticophobia among healthcare professionals, which could improve treatment adherence and patient outcomes. Further research and targeted educational interventions are necessary to enhance understanding and confidence in prescribing topical corticosteroids among healthcare professionals.
References
Das A, Panda S. A Treatise on Topical Corticosteroids in Dermatology. In: An Evidence Based Approach of Use of Topical Corticosteroids in Dermatology. Springer; 2018:41-72.
Coondoo A, Sengupta S. Topical corticophobia among parents and caregivers of atopic children. Indian J Paediatr Dermatology. 2016;17(4):255-257.
Gelmetti C. Il Giornale Italiano di Dermatologia e Venereologia. In: Storia Della Dermatologia e Della Venereologia in Italia. Springer; 2015:181-192.
Dufresne H, Bataille P, Bellon N, et al. Risk factors for corticophobia in atopic dermatitis. J Eur Acad Dermatology Venereol. 2020;34(12):e846-e849. doi:https://doi.org/10.1111/jdv.16739
Bos B, Antonescu I, Osinga H, Veenje S, de Jong K, de Vries TW. Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers. Pediatr Dermatol. 2019;36(1):100-104. doi:https://doi.org/10.1111/pde.13698
Lambrechts L, Gilissen L, Morren M-A. Topical corticosteroid phobia among healthcare professionals using the TOPICOP score. Acta Derm Venereol. 2019;99(11):1004-1008.
Choi E, Chandran NS, Tan C. Corticosteroid phobia: a questionnaire study using TOPICOP score. Singapore Med J. 2020;61(3):149-153. doi:10.11622/smedj.2019110
Silverberg JI, Nelson DB, Yosipovitch G. Addressing treatment challenges in atopic dermatitis with novel topical therapies. J Dermatolog Treat. 2016;27(6):568-576. doi:10.1080/09546634.2016.1174765
Aubert-Wastiaux H, Moret L, Le Rhun A, et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol. 2011;165(4):808-814. doi:10.1111/j.1365-2133.2011.10449.x
Lee JY, Her Y, Kim CW, Kim SS. Topical Corticosteroid Phobia among Parents of Children with Atopic Eczema in Korea. Ann Dermatol. 2015;27(5):499-506. doi:10.5021/ad.2015.27.5.499
Gustavsen HE, Gjersvik P. Topical corticosteroid phobia among parents of children with atopic dermatitis in a semirural area of Norway. J Eur Acad Dermatol Venereol. 2016;30(1):168. doi:10.1111/jdv.12670
Smith SD, Harris V, Lee A, Blaszczynski A, Fischer G. General practitioners knowledge about use of topical corticosteroids in paediatric atopic dermatitis in Australia. Aust Fam Physician. 2017;46(5):335-340.
Alsukait SF, Alshamlan NM, Alhalees ZZ, Alsuwaidan SN, Alajlan AM. Topical corticosteroids knowledge, attitudes, and practices of primary care physicians. Saudi Med J. 2017;38(6):662-665. doi:10.15537/smj.2017.6.17586
Smith SD, Lee A, Blaszczynski A, Fischer G. Pharmacists’ knowledge about use of topical corticosteroids in atopic dermatitis: Pre and post continuing professional development education. Australas J Dermatol. 2016;57(3):199-204. doi:10.1111/ajd.12339
Published
Issue
Section
License
Copyright (c) 2024 Abdullah Alakeel, Abeer Alkahtani, Rahaf Alshareef, Norah Almajli, Khalid Alekrish
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
